Opioid (painkiller) addiction is one of the greatest epidemics of our time, and luckily America is taking action on this debilitating situation politically, which has been a long time in the making.

Did you know that after long-term taking pain-killers in the form of opioids you completely blunt you body’s NAD level?

NAD is essential to protect tissues, induce DNA repair, and increase life span. NAD therapy has been seen to greatly reduce cravings and withdrawal symptoms from alcohol and opioids.

Now what is super interesting here is that the peptide BPC 157 has been shown to be able to regenerate damaged nerves in areas linked to pain i.e. combating chronic back pain for good.

This break-through treatment method is making opioids obsolete for pain management.

“BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration of tendon fibroblasts, which is likely mediated by the activation of the FAK-paxillin pathway.” (1)

And also worth noting is, that this peptide has shown promise with regards to brain injury:

“Brain-trauma study demonstrated that BPC 157 may preserve consciousness and lower brain edema, decrease the number and size of the hemorrhagic traumatic lacerations, and mitigate the intensity of subarachnoidal bleeding with significantly decreased intraventricular hemorrhage, and diminish mortality [68]. Also in supportive analogy, after contusion, BPC 157 (given locally or intraperitoneally) improved crushed muscle healing, with less post-injury haematoma and edema and a complete restitution of function. “ (2)

Read the full studies below and ask your physician about treatment with BPC 157 if you suffer with chronic pain or brain injury.

References:

1) J Appl Physiol (1985). 2011 Mar;110(3):774-80. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Chang CH

2) Curr Neuropharmacol. 2016 Nov; 14(8): 857–865. Published online 2016 Nov. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications Predrag Sikiric,1,